Autologous T cells transduced with anti-CD19 CARs have been reported to induce complete remission in patients with chronic lymphoblastic leukemia (CLL) and acute lymphoblastic leukemia (ALL) [17]–[20]. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.